Skip to content
Search

Latest Stories

RPS responds to DHSC’s consultation on smokefree generation and youth vaping

RPS responds to DHSC’s consultation on smokefree generation and youth vaping

All tobacco products, cigarette papers and herbal smoking products should be covered in the new legislation, says RPS  

The Royal Pharmaceutical Society (RPS) has said that it strongly supports the UK government’s proposal that individuals born on or after 1 January 2009 should be prohibited from legally purchasing tobacco products.


It has also shown its agreement to several other actions proposed by the Department of Health and Social Care's (DHSC) for ‘Creating a Smokefree Generation and Tackling Youth Vaping’ including:

  • The inclusion of all tobacco products, cigarette papers, and herbal smoking products in the new legislation.
  • Restrictions on the sale and supply of disposable vapes, and vape flavours.

RPS President, Professor Claire Anderson, said: "Our recommendations reflect a commitment to creating a future free from the harms of tobacco and youth vaping. It's crucial to prohibit access for the youngest generation, regulate all tobacco-related items, and address the allure of flavoured e-cigarettes.”

The organisation said that it has outlined the key recommendations to address the pressing issue of youth vaping and tobacco consumption, drawing on its e-cigarette policy and the expertise of its Science and Research committee.

Restrict sale for tobacco products to adolescents  

RPS explained that the age of sale for tobacco products should be changed to prohibit adolescents from legally purchasing the products, as “the adolescent phase, spanning from 12 to 18 years in humans, emerges as a particularly vulnerable period for the maturation of brain circuits governing cognition and emotion, rendering it susceptible to the impacts of nicotine and tobacco.”

“Prolonged exposure to nicotine during adolescence triggers noteworthy alterations in neurochemistry and behaviour,” it said.

Further, it stated that individuals who refrain from initiating smoking during adolescence are “statistically less inclined to take up smoking later in life.”

Proxy sales should also be prohibited

RPS also opined that anyone born before 1 January 2009 should be prohibited from purchasing tobacco products on behalf of anyone born on or after 1 January 2009 because “they increase accessibility and exposure of adolescents to tobacco.”

“Prohibiting the proxy sale of tobacco-containing products to adolescents aligns with a broader commitment to promoting public health, preventing addiction, and ensuring the wellrounded development of young individuals during a crucial stage of their lives,” it explained.

The organisation believes that including all tobacco products, including cigarettes, smokeless tobacco, and herbal smoking alternatives, in the new legislation, will ensure “uniform protection against the harmful effects associated with the use of these products.”

“This approach prevents potential loopholes that could be exploited by the relevant industry to market alternative products to adolescents,” it said.

Restrict vape flavours

The RPS agreed that the UK Government and devolved administrations should restrict vape flavours, and suggested that limiting the characterising flavours (the taste and smell) of vapes would be the most effective way to do so.

To check use of vape flavours in children and young people, they recommended restricting flavours to tobacco only, as it “eliminates the appeal of sweet and fruity flavours that often attract young people to start vaping.”

Additionally, it outlined the need for restrictions on the sale and supply of disposable vapes, particularly those that are not rechargeable, not refillable, or neither rechargeable nor refillable.

“Restricting the sale of non-rechargeable and non-refillable vapes aligns with broader environmental sustainability goals. Disposable vapes contribute significantly to environmental harm due to their single-use nature. The batteries and materials used in these devices can pose challenges for proper disposal and recycling,” it said.

The RPS is also in favour of the inclusion of non-nicotine e-liquid, for example shortfills, in restrictions on vape flavours.

Moreover, it opined that vapes shouldn’t be allowed to be displayed at the point of sale, like tobacco products, to limit the exposure of children.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less